Inhibition of osteoclastogenesis by RNA interference targeting RANK. - Wikidata - wikimedia - TriplyDB

Inhibition of osteoclastogenesis by RNA interference targeting RANK.

Inhibition of osteoclastogenesis by RNA interference targeting RANK.

http://www.wikidata.org/entity/Q34389834

about

Osteoblastic NF-κB pathway is involved in 1α, 25(OH)2D3-induced osteoclast-like cells formation in vitro.The RANK/RANKL/OPG system in tumorigenesis and metastasis of cancer stem cell: potential targets for anticancer therapy.

P2860

Q35854504-C69100FB-D7D7-4171-A70F-C8C48D651688 Q41200607-FCA88581-8B5D-40FE-9764-5AE76DEF6E54

P2860

Inhibition of osteoclastogenesis by RNA interference targeting RANK.

http://www.wikidata.org/entity/Q34389834

description

2012 nî lūn-bûn

@nan

2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Inhibition of osteoclastogenesis by RNA interference targeting RANK.

@ast

Inhibition of osteoclastogenesis by RNA interference targeting RANK.

@en

Inhibition of osteoclastogenesis by RNA interference targeting RANK.

@nl

type

label

Inhibition of osteoclastogenesis by RNA interference targeting RANK.

@ast

Inhibition of osteoclastogenesis by RNA interference targeting RANK.

@en

Inhibition of osteoclastogenesis by RNA interference targeting RANK.

@nl

prefLabel

Inhibition of osteoclastogenesis by RNA interference targeting RANK.

@ast

Inhibition of osteoclastogenesis by RNA interference targeting RANK.

@en

Inhibition of osteoclastogenesis by RNA interference targeting RANK.

@nl

P1433

Q34389834-E67ABC71-B4AE-4A9E-936F-0BCF5FF08D9D

P1476

Q34389834-C4A86A21-B71B-45EA-82E0-A004D212D7B1

P2093

Q34389834-140EA7C9-EF30-4552-915C-DFA48C93F961

Q34389834-61CDC70D-E759-4B85-BFE5-DA36B78E7A34

Q34389834-6D9FCF90-CA5C-45DC-A0FE-CF1A4715EDF4

Q34389834-8A9D6EC9-DD6F-48F6-A2F6-4FBB0AA9F801

Q34389834-995DB9AE-7212-4ADF-AB65-8EEB00113A76

P2860

Q34389834-0403EAF3-EB43-4589-AD5B-027F3FBEBD48

Q34389834-0F49CC4B-4CD1-4ABB-974E-379443501C48

Q34389834-151AB4C3-12C8-454C-91D3-D2DF902571AC

Q34389834-1EDA6F3A-8CB6-4FF8-890E-A27F573F1BBD

Q34389834-25DD8FDD-2F1A-4B8B-ABBC-BD817781AF33

Q34389834-2FD6FBB2-A47F-4D11-923F-4DE1DAFED93D

Q34389834-38617FD0-0F90-464B-9619-11F92A362F6F

Q34389834-3D3A5E4C-FA4F-498B-9EFE-9E5F377AE066

Q34389834-415A5C0B-8CBC-4E2E-A16D-5FD1B9A27410

Q34389834-4C7C6D7C-3CCF-4804-82B3-C028281E2E57

P2888

Q34389834-426FBCCC-018F-4C23-8D65-C907ABE8C384

P304

Q34389834-D1E481EC-37CE-4C1C-BA61-AD22C2E48E10

P31

Q34389834-A34D6ADC-B219-4EB2-BF37-25A3EE4515E6

P356

Q34389834-135D213F-FFAC-4A3A-9A27-C2FE7D707029

P478

Q34389834-6D29662D-EEA4-425C-A047-0F320A8F2DCF

P50

Q34389834-4DF5D327-A65C-4E63-8679-31D109879E25

P577

Q34389834-DE00EFB6-07B6-4319-A51C-A3A0A5B84A59

P5875

Q34389834-DCDE2DDE-88E6-492A-855F-C1866C426DF0

P6179

Q34389834-037F4BA3-7E39-406B-AAE0-ADF3F4113A81

P698

Q34389834-FF83EE0A-E5C9-483A-B176-1A39DA1A7B57

P932

Q34389834-A0674B83-95A7-4FFD-B703-E168D9FC76EC

P356

1471-2474-13-154

P1433

BMC Musculoskeletal Disorders

P1476

Inhibition of osteoclastogenesis by RNA interference targeting RANK

@en

P2093

Bin Dong

http://www.w3.org/2001/XMLSchema#string

Christian Wedemeyer

http://www.w3.org/2001/XMLSchema#string

Jie Xu

http://www.w3.org/2001/XMLSchema#string

Marcus Jäger

http://www.w3.org/2001/XMLSchema#string

Ruofan Ma

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand

Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families

The TNF and TNF receptor superfamilies: integrating mammalian biology

Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase

Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system

RANKL-RANK signaling in osteoclastogenesis and bone disease

RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis

RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapies

Osteoclast differentiation and activation

Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice

P2888

1471-2474-13-154

P304

154

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2474-13-154

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Max Daniel Kauther

P577

2012-08-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230721288

http://www.w3.org/2001/XMLSchema#string

P6179

1047200459

http://www.w3.org/2001/XMLSchema#string

P698

22913338

http://www.w3.org/2001/XMLSchema#string

P932

3475138

http://www.w3.org/2001/XMLSchema#string